The results of functional experiments showed that TXNDC12 had enhanced ability to promote endothelial cell tube-formation while promoting cervical cancer cell migration, so TXNDC12 is hopeful as a new target in the AGS group for anti-angiogenic therapy, and improve new thinking and research direction for clinical treatment. This evidence concerns the gene TXNDC12 and cervical cancer.